The leadership team at BioAge has a wealth of experience in the biopharma industry and in various aspects of drug development. Members of the team have worked as consultants, managers, and executives at a variety of companies, including Principia Biopharma, Science 37, and Biotie Therapies (f/n/a Synosia Therapeutics Inc.). They have also held positions at academic institutions such as the University of Minnesota, Princeton University, and the David Geffen School of Medicine at UCLA.
View all